22.5% body weight loss in 72 weeks; the science is settled
- Dual GIP + GLP-1 receptor agonism; outperforms semaglutide in every head-to-head trial
- Kills food noise, stabilizes blood sugar, and reshapes your metabolic baseline
- The compound behind Mounjaro and Zepbound; in research-grade lyophilized form
Tirzepatide is the compound behind Mounjaro and Zepbound; and it earned those brand names by outperforming every GLP-1 drug ever tested in head-to-head trials. By targeting both GIP and GLP-1 receptors simultaneously, it achieves something semaglutide alone cannot: the dual-agonist mechanism amplifies fat metabolism, reduces GI side effects over time, and reshapes insulin sensitivity at a systemic level. In the SURMOUNT-1 trial, participants at the highest dose lost an average of 22.5% of their body weight over 72 weeks. If you're benchmarking weight-loss compounds, tirzepatide is the standard everything else is measured against.
Tirzepatide
Original price was: ฿6,000.00.฿4,000.00Current price is: ฿4,000.00.
save 6–12% on orders of 3+ vialsA standard dose-response study (8–12 weeks, 3 cohorts) typically requires 3–5 vials. Order 3+ to activate tier pricing.
For research use only. Not for human or veterinary consumption. In-vitro laboratory use only.
Bank Transfer · BTC · ETH · USDC · USDT · SOL
Description
What It Does
- Clinical-level weight loss benchmarking; the most proven dual-agonist available
- Comparing GIP + GLP-1 dual agonism vs single-target compounds like semaglutide
- Blood sugar regulation and insulin sensitivity in metabolic disease models
- Lipid profile improvement and cardiovascular risk factor reduction
- Appetite suppression, food intake reduction, and gastric motility modulation
How to Reconstitute
Allow the vial to equilibrate to room temperature before opening. Reconstitute in sterile water for injection or 0.1% acetic acid to your required working concentration. Do not vortex; gently swirl or invert the vial until fully dissolved. Aliquot into single-use volumes to avoid repeated freeze-thaw.
Storage
Store lyophilized vials at −20°C in the original sealed container, protected from moisture and light. Lyophilized material stays stable for up to 24 months when stored correctly. Reconstituted peptide solutions should be stored at −80°C and used within 30 days. Avoid repeated freeze-thaw cycles.
What’s Included
- 1 × Tirzepatide lyophilized vial ; 30mg
- Batch number and expiry date printed on vial label
- Discreet external packaging with no product name or branding on the exterior


